PepAxiom

Growth hormone / secretagogues

IGF-1 DES

Research chemical

DES(1-3) IGF-1 · IGF-1 analog

Truncated, highly potent short-acting IGF-1 variant.

Half-life
Short (minutes)
Route
Subcutaneous
Evidence
Anecdotal / research-chemical; no human approval.

What it is

A truncated IGF-1 (missing the first three amino acids) with very high local potency and a short half-life. Research chemical.

How it works

Binds IGF-1 receptors with high affinity and low binding-protein affinity for potent, localized anabolic signaling.

Studied for

Localized muscle-growth claims (anecdotal).

Regulatory status

Not FDA-approved; research chemical; WADA-prohibited.

Safety

Hypoglycemia risk and theoretical proliferative/cancer concerns; no human safety data.

Reconstitution calculator →

Educational information only — not medical advice, and not a recommendation to use any compound. Many peptides here are not approved for human use; legal status and evidence quality vary and are noted above. This page contains no dosing information. Consult a qualified clinician before making any health decision.